Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Homology Medicines, Inc.

Homology Medicines, Inc. (FIXX) Stock Overview

Explore Homology Medicines, Inc.’s financial performance, market position, analyst ratings, and future outlook.

FIXX●NASDAQ
HealthcareBiotechnology
$0.93
$0.007(0.77%)
U.S. Market opens in 35h 2m

Homology Medicines, Inc. (FIXX)

Meyka AI Score

Z

Key Financials

Market Cap3M
P/E Ratio0.35
EPS (TTM)$-35.10
ROE2.83%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

FIXX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Homology Medicines, Inc. (NASDAQ: FIXX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Homology Medicines, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of FIXX on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Homology Medicines, Inc.'s NASDAQ-traded stock include a P/E ratio of 0.35 and a market capitalization of 3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of FIXX on the NASDAQ.

Price Performance (NASDAQ: FIXX)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-94.40%
3-Month Change
-91.24%
6-Month Change
-94.91%
Year-to-Date (YTD) Change
-91.39%
1-Year Change
-94.75%
3-Year Change
-99.25%
5-Year Change
-99.76%
All-Time (Max) Change
-99.72%

Contact Information

https://www.homologymedicines.com
781 301 7277
One Patriots Park, Bedford, MA, 01730

Company Facts

70 Employees
IPO DateMar 28, 2018
CountryUS

Frequently Asked Questions